NCT02293993View on ClinicalTrials.gov

Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

January 7, 2015

Primary Completion Date

June 14, 2017

Study Completion Date

May 31, 2019

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

SGI-110

Trial Locations (3)

Unknown

kinki Region, Kyoto

Kanto, Region

Kyusyu, Region

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY